Repost from Business Wire here:

Systems Oncology to Present at Upcoming Scientific and Investor Conferences

SCOTTSDALE, AZ, Sept, 7, 2021 — Systems Oncology LLC, a privately held biopharmaceutical company developing a new class of multi-modal RNA therapeutics, announced today that the management team will be presenting and participating at the following upcoming conferences:

H.C. Wainwright 23rd Annual Global Investment Conference
Company Presentation
Presented by Dr. Spyro Mousses, CEO
September 10th, 2021, 3:00pm ET
Virtual
Archived replay: click here

Wells Fargo 2021 Virtual Healthcare Conference
Fireside Chat
Presented by Dr. Spyro Mousses, CEO
September 10th, 2021, 4:00pm ET
Virtual
Archived replay: click here

TIDES USA Conference
Arromer – Receptor Directed Delivery for Ultra-precise RNAi Multi-targeting
Presented by Dr. Spyro Mousses, CEO
September 23rd, 2021, 12:20pm ET
Boston, MA

About Systems Oncology:

Systems Oncology is developing a new class of multimodal RNA therapeutics that simultaneously silence the right combination of disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which are directed to specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of drug products in oncology, yet our multimodal RNA therapeutics platform can be harnessed to transform outcomes for any complex polygenic disease.

Company & Investors Contact:
Andrew Matricaria, CFO
andrew@systemsoncology.com
(312) 952-3451

Media Contact:
Courtney Villani
CVillani@systemsoncology.com
(619) 807-1467